The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Humphrey Rachel since 2016.
The trader's CIK number is 1579781.
At the time of the last reporting, Humphrey Rachel was the Chief Medical Officer of Cytomx Therapeutics, Inc.. (stock ticker symbol CTMX).
Also see all insider trading activities at Cytomx Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | CTMX | 0 | $0 | 40,000 | $1,200,000 | 40,000 | $264,599 |
| 2017 | CTMX | 0 | $0 | 0 | $0 | 15,117 | $99,998 |
| 2016 | CTMX | 0 | $0 | 0 | $0 | 15,117 | $99,998 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-03-02 | CTMX | Sale | 16,160 | 30.00 | 484,800 |
| 2018-03-02 | CTMX | Option Ex | 16,160 | 6.62 | 106,898 |
| 2018-02-28 | CTMX | Sale | 23,840 | 30.00 | 715,200 |
| 2018-02-28 | CTMX | Option Ex | 23,840 | 6.62 | 157,701 |
| 2017-12-15 | CTMX | Option Ex | 15,117 | 6.62 | 99,998 |
| 2016-12-28 | CTMX | Option Ex | 15,117 | 6.62 | 99,998 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Humphrey Rachel (Chief Medical Officer of Cytomx Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.